S J H van Deventer
Overview
Explore the profile of S J H van Deventer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1038
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huibregtse I, van Lent A, van Deventer S
Gut
. 2006 Oct;
56(4):584-92.
PMID: 17047100
No abstract available.
2.
van Deventer S, Wedel M, Baker B, Xia S, Chuang E, Miner Jr P
Aliment Pharmacol Ther
. 2006 May;
23(10):1415-25.
PMID: 16669956
Background: Alicaforsen is an antisense oligonucleotide designed to inhibit expression of human intercellular adhesion molecule 1. Previous clinical studies have demonstrated activity of alicaforsen enema in ulcerative colitis and pouchitis....
3.
Reinisch W, Hommes D, Van Assche G, Colombel J, Gendre J, Oldenburg B, et al.
Gut
. 2006 Feb;
55(8):1138-44.
PMID: 16492717
Introduction: This study was designed to evaluate the safety of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease (CD). Patients And Methods: Forty five...
4.
Willemsen L, Hoetjes J, van Deventer S, van Tol E
Clin Exp Immunol
. 2005 Oct;
142(2):275-84.
PMID: 16232214
The intestinal barrier function is often impaired in a variety of diseases including chronic inflammatory bowel disease. Increased intestinal permeability during episodes of active disease correlates with destruction or rearrangement...
5.
Levels J, Marquart J, Abraham P, van den Ende A, Molhuizen H, van Deventer S, et al.
Infect Immun
. 2005 Mar;
73(4):2321-6.
PMID: 15784577
Lipopolysaccharide (LPS), the major outer membrane component of gram-negative bacteria, is a potent endotoxin that triggers cytokine-mediated systemic inflammatory responses in the host. Plasma lipoproteins are capable of LPS sequestration,...
6.
de Visser M, van Ballegooijen M, Bloemers S, van Deventer S, J B M J Jansen , Jespersen J, et al.
Cell Oncol
. 2005 Mar;
27(1):17-29.
PMID: 15750204
A consensus development meeting was held to evaluate whether or not in the Netherlands all requirements were fulfilled for implementation of population screening with FOBT for colorectal cancer, or whether...
7.
van Deventer S, Tami J, Wedel M
Gut
. 2004 Oct;
53(11):1646-51.
PMID: 15479686
Objective: To evaluate the safety and efficacy of an enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule, after 1, 3, and 6 months. Methods: This was a...
8.
Peppelenbosch M, van Deventer S
Gut
. 2004 Oct;
53(11):1556-8.
PMID: 15479669
No abstract available.
9.
Erkelens G, van Deventer S
Best Pract Res Clin Gastroenterol
. 2004 May;
18(1):201-7.
PMID: 15123092
Patients with Crohn's disease often develop (recurring) intestinal stenosis. This is a result of continuous activation of fibrogenic cells by ongoing inflammation. Surgery is usually needed and consists of intestinal...
10.
Dunker M, Ten Hove T, Bemelman W, Slors J, Gouma D, van Deventer S
Dis Colon Rectum
. 2003 Sep;
46(9):1238-44.
PMID: 12972969
Purpose: The aim of the study was to investigate the effect of surgical trauma in terms of approach (laparoscopic vs. conventional surgery) and extent of bowel resection (ileocolic resection vs....